Related references
Note: Only part of the references are listed.Endocytosis: a pivotal pathway for regulating metastasis
Imran Khan et al.
BRITISH JOURNAL OF CANCER (2021)
Clathrin-mediated EGFR endocytosis as a potential therapeutic strategy for overcoming primary resistance of EGFR TKI in wild-type EGFR non-small cell lung cancer
Boyeon Kim et al.
CANCER MEDICINE (2021)
Is the risk of cancer in Australia overstated? The importance of competing mortality for estimating lifetime risk
Anthea C. Bach et al.
MEDICAL JOURNAL OF AUSTRALIA (2020)
Amino Alcohol Acrylonitriles as Activators of the Aryl Hydrocarbon Receptor Pathway: An Unexpected MTT Phenotypic Screening Outcome
Jennifer R. Baker et al.
CHEMMEDCHEM (2020)
Endocytosis Inhibition in Humans to Improve Responses to ADCC-Mediating Antibodies
Hui Yi Chew et al.
CELL (2020)
Small molecules, big impact: 20 years of targeted therapy in oncology
Philippe L Bedard et al.
LANCET (2020)
Improving Membrane Permeation in the Beyond Rule-of-Five Space by Using Prodrugs to Mask Hydrogen Bond Donors
Nicholas Barlow et al.
ACS CHEMICAL BIOLOGY (2020)
Mechanisms of Cancer Resistance to Immunotherapy
Rilan Bai et al.
FRONTIERS IN ONCOLOGY (2020)
Evolving models for assembling and shaping clathrin-coated pits
Zhiming Chen et al.
JOURNAL OF CELL BIOLOGY (2020)
Dynamin 1 is important for microtubule organization and stabilization in glomerular podocytes
The Mon La et al.
FASEB JOURNAL (2020)
Opportunities for Small Molecules in Cancer Immunotherapy
Sabina Y. van der Zanden et al.
TRENDS IN IMMUNOLOGY (2020)
Small molecule inhibition of Dynamin-dependent endocytosis targets multiple niche signals and impairs leukemia stem cells
Cedric S. Tremblay et al.
NATURE COMMUNICATIONS (2020)
Changes in cancer incidence and mortality in Australia over the period 1996-2015
Qingwei Luo et al.
BMC RESEARCH NOTES (2020)
A Direct Podocalyxin-Dynamin-2 Interaction Regulates Cytoskeletal Dynamics to Promote Migration and Metastasis in Pancreatic Cancer Cells
Bin Sheng Wong et al.
CANCER RESEARCH (2019)
Cell signaling and cancer: a mechanistic insight into drug resistance
Munmun Panda et al.
MOLECULAR BIOLOGY REPORTS (2019)
The Blood-Brain Barrier (BBB) Score
Mayuri Gupta et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Functional recruitment of dynamin requires multimeric interactions for efficient endocytosis
Morgane Rosendale et al.
NATURE COMMUNICATIONS (2019)
Mitosis inhibitors in anticancer therapy: When blocking the exit becomes a solution
Ana C. Henriques et al.
CANCER LETTERS (2019)
The Next Generation of Immunotherapy for Cancer: Small Molecules Could Make Big Waves
William G. Kerr et al.
JOURNAL OF IMMUNOLOGY (2019)
From Flat to Curved Clathrin: Controlling a Plastic Ratchet
Kem A. Sochacki et al.
TRENDS IN CELL BIOLOGY (2019)
The dynamin superfamily
Rajesh Ramachandran et al.
CURRENT BIOLOGY (2018)
PROSTATE CANCER Revealing mechanisms of resistance
Louise Stone
NATURE REVIEWS UROLOGY (2018)
Targeting the cell cycle in breast cancer: towards the next phase
K. L. Thu et al.
CELL CYCLE (2018)
Hedgehog Signaling Pathway and Autophagy in Cancer
Xian Zeng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Dynamin 2 (DNM2) as Cause of, and Modifier for, Human Neuromuscular Disease
Mo Zhao et al.
NEUROTHERAPEUTICS (2018)
Reducing dynamin 2 (DNM2) rescues DNM2-related dominant centronuclear myopathy
Suzie Buono et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Efficacy and Tolerability of 5-Year Adjuvant Imatinib Treatment for Patients With Resected Intermediate-or High-Risk Primary Gastrointestinal Stromal Tumor The PERSIST-5 Clinical Trial
Chandrajit P. Raut et al.
JAMA ONCOLOGY (2018)
The argument for using imatinib in CML
Simone Claudiani et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2018)
Pyrimidine-Based Inhibitors of Dynamin I GTPase Activity: Competitive Inhibition at the Pleckstrin Homology Domain
Luke R. Odell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Notch signaling pathway networks in cancer metastasis: a new target for cancer therapy
Li Li et al.
MEDICAL ONCOLOGY (2017)
Strategies and challenges for the next generation of antibody drug conjugates
Alain Beck et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
A highly-sensitive high throughput assay for dynamin's basal GTPase activity
Aparna Mohanakrishnan et al.
PLOS ONE (2017)
Synthesis and Antineoplastic Evaluation of Mitochondrial Complex II (Succinate Dehydrogenase) Inhibitors Derived from Atpenin A5
Hezhen Wang et al.
CHEMMEDCHEM (2017)
Mechanisms of GTP Hydrolysis and Conformational Transitions in the Dynamin Superfamily
Oliver Daumke et al.
BIOPOLYMERS (2016)
Membrane fission by dynamin: what we know and what we need to know
Bruno Antonny et al.
EMBO JOURNAL (2016)
Role of dynamin in elongated cell migration in a 3D matrix
Justin G. Lees et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2015)
Antimitotic drugs in the treatment of cancer
Rustelle Janse van Vuuren et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
Targeted therapy in cancer
Apostolia-Maria Tsimberidou
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
Targeting Mitosis in Cancer: Emerging Strategies
Carmen Dominguez-Brauer et al.
MOLECULAR CELL (2015)
Crystal structure of the dynamin tetramer
Thomas F. Reubold et al.
NATURE (2015)
1,8-Naphthalimide derivatives: new leads against dynamin I GTPase activity
Mohammed K. Abdel-Hamid et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2015)
Insoluble drug delivery strategies: review of recent advances and business prospects
Sandeep Kalepu et al.
ACTA PHARMACEUTICA SINICA B (2015)
Development of quinone analogues as dynamin GTPase inhibitors
Kylie A. MacGregor et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Synthesis of Dynole 34-2, Dynole 2-24 and Dyngo 4a for investigating dynamin GTPase
Mark J. Robertson et al.
NATURE PROTOCOLS (2014)
EGFR endocytosis is a novel therapeutic target in lung cancer with wild-type EGFR
Ukhyun Jo et al.
ONCOTARGET (2014)
A Dynamin Mutant Defines a Superconstricted Prefission State
Anna C. Sundborger et al.
CELL REPORTS (2014)
Pyrimidyn Compounds: Dual-Action Small Molecule Pyrimidine-Based Dynamin Inhibitors
Andrew B. McGeachie et al.
ACS CHEMICAL BIOLOGY (2013)
Dynamin 2 Potentiates Invasive Migration of Pancreatic Tumor Cells through Stabilization of the Rac1 GEF Vav1
Gina L. Razidlo et al.
DEVELOPMENTAL CELL (2013)
Development of Second-Generation Indole-Based Dynamin GTPase Inhibitors
Christopher P. Gordon et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Building a Better Dynasore: The Dyngo Compounds Potently Inhibit Dynamin and Endocytosis
Adam McCluskey et al.
TRAFFIC (2013)
Targeting membrane trafficking in infection prophylaxis: dynamin inhibitors
Callista B. Harper et al.
TRENDS IN CELL BIOLOGY (2013)
Dynamin 2 mutations in Charcot-Marie-Tooth neuropathy highlight the importance of clathrin-mediated endocytosis in myelination
Paris N. M. Sidiropoulos et al.
BRAIN (2012)
Increased expression of the large GTPase dynamin 2 potentiates metastatic migration and invasion of pancreatic ductal carcinoma
R. D. Eppinga et al.
ONCOGENE (2012)
The Rhodadyns, a New Class of Small Molecule Inhibitors of Dynamin GTPase Activity
Mark J. Robertson et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
Phosphorylation of dynamin II at serine-764 is associated with cytokinesis
Megan Chircop et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Dynamin Inhibition Blocks Botulinum Neurotoxin Type A Endocytosis in Neurons and Delays Botulism
Callista B. Harper et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Dynamin inhibitors induce caspase-mediated apoptosis following cytokinesis failure in human cancer cells and this is blocked by Bcl-2 overexpression
Sanket Joshi et al.
MOLECULAR CANCER (2011)
Inhibition of Dynamin by Dynole 34-2 Induces Cell Death following Cytokinesis Failure in Cancer Cells
Megan Chircop et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Calcineurin activity is required for the completion of cytokinesis
Megan Chircop et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Building a Tiered Approach to In Vitro Predictive Toxicity Screening: A Focus on Assays with In Vivo Relevance
James M. McKim
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2010)
The Pthaladyns: GTP Competitive Inhibitors of Dynamin I and II GTPase Derived from Virtual Screening
Luke R. Odell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Iminochromene Inhibitors of Dynamins I and II GTPase Activity and Endocytosis
Timothy A. Hill et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Dynamin 2 is required for actin assembly in phagocytosis in Sertoli cells
Atsushi Otsuka et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Dynasore, a dynamin inhibitor, suppresses lamellipodia formation and cancer cell invasion by destabilizing actin filaments
Hiroshi Yamada et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Azido and Diazarinyl Analogues of Bis-Tyrphostin as Asymmetrical Inhibitors of Dynamin GTPase
Luke R. Odell et al.
CHEMMEDCHEM (2009)
Inhibition of Dynamin Mediated Endocytosis by the Dynoles-Synthesis and Functional Activity of a Family of Indoles
Timothy A. Hill et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
From Spanish fly to room-temperature ionic liquids (RTILs): synthesis, thermal stability and inhibition of dynamin 1 GTPase by a novel class of RTILs
Jie Zhang et al.
NEW JOURNAL OF CHEMISTRY (2008)
Myristyl trimethyl ammonium bromide and octadecyl trimethyl ammonium bromide are surface-active small molecule dynamin inhibitors that block endocytosis mediated by dynamin I or dynamin II
Annie Quan et al.
MOLECULAR PHARMACOLOGY (2007)
A Sorcerer's apprentice and the rule of five: from rule-of-thumb to commandment and beyond
Cele Abad-Zapatero
DRUG DISCOVERY TODAY (2007)
Targeted anti-mitotic therapies: can we improve on tubulin agents?
Jeffrey R. Jackson et al.
NATURE REVIEWS CANCER (2007)
Dynasore, a cell-permeable inhibitor of dynamin
Eric Macia et al.
DEVELOPMENTAL CELL (2006)
Small molecule inhibitors of dynamin I GTPase activity: Development of dimeric tyrphostins
T Hill et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
The dynamin superfamily: Universal membrane tubulation and fission molecules?
GJK Praefcke et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Aurora-kinase inhibitors as anticancer agents
N Keen et al.
NATURE REVIEWS CANCER (2004)
Long chain amines and long chain ammonium salts as novel inhibitors of dynamin GTPase activity
TA Hill et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Regulated portals of entry into the cell
SD Conner et al.
NATURE (2003)
Neurodegeneration in Niemann-Pick type C disease mice
WY Ong et al.
EXPERIMENTAL BRAIN RESEARCH (2001)
HIP1 functions in clathrin-mediated endocytosis through binding to clathrin and adaptor protein 2
M Metzler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
